Indeed, a previous study has found that IgM anti-PC autoantibodies significantly increased during 1-year anti-TNF treatment in patients with RA, possibly through a direct inhibitory effect of TNF on B-cells producing anti-PC, or indirectly through decreased systemic inflammation [45]. This evidence concerns the gene TNF and rheumatoid arthritis.